Right-sided CRC frequently harbors Class 1 BRAF mutations, a finding that is compatible with the fact that tumors deriving from this tissue are largely driven by EGFR-independent oncogenic inputs [14]. The gene discussed is EGFR; the disease is colorectal carcinoma.